By Michele Maatouk
Date: Monday 18 May 2026
(Sharecast News) - Boston Scientific said on Monday that it has invested $1.5bn in privately-held MiRus in exchange for a 34% stake, with an exclusive option to buy the company's novel balloon-expandable aortic valve business.
| Market movers | 26-Feb-2008 | Chicago Tribune |
| Abbott falls behind in stents race | 01-Sep-2007 | Chicago Tribune |
| Rumors of rate cut lift stocks | 17-Aug-2007 | LA Times |
| Stent studies buoy Abbott | 23-May-2007 | Chicago Tribune |
| Johnson & Johnson's heart stent fails trial, der... | 08-May-2007 | Intl Herald Tribune |
| Currency | US Dollars |
| Share Price | $ 42.73 |
| Change Today | $ 0.69 |
| % Change | 1.64 % |
| 52 Week High | $104.98 |
| 52 Week Low | $41.58 |
| Volume | 13,037,399 |
| Shares Issued | 1,483.00m |
| Market Cap | $63,369m |
| RiskGrade | 132 |
| Strong Buy | 11 |
| Buy | 12 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 16:00 | 1,832,958 @ $42.73 |
| 16:00 | 129 @ $42.74 |
| 16:00 | 100 @ $42.74 |
| 16:00 | 8,720 @ $42.74 |
| 16:00 | 900 @ $42.74 |
You are here: research